RE:Lucira looks promisingjsim082 wrote: This new partnership with Lucira looks like a very nice piece of work by DM.
Per Lucira's earnings call transcript for Q1 2022 they were receiving orders from Health Canada for the purpose of "providing value to remote and hard to reach communities". This sounds like a goal DM has also expressed.
(Source: https://www.fool.com/earnings/call-transcripts/2022/05/13/lucira-health-inc-lhdx-q1-2022-earnings-call-trans/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article)
Also, Lucira does a significant amount of business, with 34 million in total revenue in the last quarter. Regardless of their negative EBITDA, that does suggest a fairly significant adoption of their product.
They are also working on other products, like Chlamydia and Gonorrhea testing.
If the eroding of our film industry test kit sales is inevitable, it could be nice to be in bed with a company like this.
Just my opinion.
JAGS
It seems that Lucira has also fallen victim to being perceived as mainly a Covid company. One year ago their stock price exceeded $8.00. Six months ago it was at Just over $3.00. today is it around $0.45. They can benefit from this new partnership just as DM can benefit. Their WEB site shows a home test kit now includes Telehealth ( from DM I assume) for a cost of $98.00 with a current sale discount of 23% off of that. We can can be sure that some of that revenue goes to DM. DM's current movie business could evaporate at the next ACTRA contract revision but until then I don't think the union members will want to test themselves at home nor can management be sure members would do it accurately at home and finally the client would not want to be involved in analysing the results. So this new home testing can only enhance the Medicall business and lead to prescription business for the new pharmacy. I see mostly upside with this news.